Trial0

Pricing

Start free. Bring in Pro when you want a PA for the process.

The map is free because families deciding under pressure should not pay to see their options. Pro adds approval-first contact research, outreach preparation and follow-up — never medical advice or a promise of enrolment.

Free

$0forever

See every frontier option whose published criteria you plausibly meet.

  • Live trial searches for any condition
  • Interventional trials and expanded-access programs
  • Per-criterion match state — matched, not matched, or honestly unknown
  • Global sites and published recruiting status
  • Email alerts when new relevant trials appear
  • Published registry data only
  • No contact research or outreach support

Pro

US$49 / £49per month

Your approval-first clinical-trial concierge.

  • Research the right study contacts and referral requirements
  • Prepare outreach and check in with you before contacting each trial
  • Follow up with study teams after you approve the next step
  • A clear status timeline for every trial you ask us to pursue
  • Available internationally; UK checkout is in GBP
  • Trial sites and clinicians make all eligibility and enrolment decisions

What does Pro include? Pro is a monthly subscription. It covers contact research, preparation and follow-up; you approve before Trial0 contacts any study on your behalf. Pro is a monthly subscription that you can cancel. Trial0 accepts no payment, commission or referral fee from any provider, site, sponsor or manufacturer, and never promises enrolment or any clinical outcome.

Can Trial0 guarantee a place on a trial? No. Trial sites and treating clinicians decide eligibility, screening and enrolment. Trial0 helps you pursue a choice you have approved.

Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.